Anebulo Pharmaceuticals, Inc. (ANEB)
NASDAQ: ANEB · Real-Time Price · USD
2.080
+0.080 (4.00%)
Sep 19, 2024, 4:00 PM EDT - Market closed
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $53.94 million as of September 19, 2024. Its market cap has decreased by -22.61% in one year.
Market Cap
53.94M
Enterprise Value
48.79M
1-Year Change
-22.61%
Ranking
Category
Stock Price
$2.08
Market Cap Chart
Since the IPO on May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from $162.86M to $53.94M, a decrease of -66.88%. That is a compound annual growth rate of -27.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2024 | 51.90M | -16.29% |
| Dec 29, 2023 | 62.00M | -0.16% |
| Dec 30, 2022 | 62.10M | -56.75% |
| Dec 31, 2021 | 143.60M | -11.83% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intensity Therapeutics | 56.05M |
| Mural Oncology | 55.20M |
| Actinium Pharmaceuticals | 55.14M |
| Aerovate Therapeutics | 55.14M |
| Eagle Pharmaceuticals | 54.93M |
| Lexaria Bioscience | 53.28M |
| Syros Pharmaceuticals | 53.08M |
| BioLineRx | 52.61M |